Wishing everyone a happy Presidents’ Day today!
Updated: February 17, 2020
Yesterday we celebrated the Birthday of Anna Florczak, GCT CRA and Safety Specialist in Poland. Anna joined our company in 2018 as Research Assistant, and has been contributing her expertise and professionalism to our global team’s work since.
Dear Anna, we hope you had a wonderful day celebrating and wish you all the best for your birthday!
Updated: February 14, 2020
On SRH Day we are aiming to increase awareness on sexual education and reproductive health – an issue important for both men and women. We urge everyone to become more knowledgeable about the topics such as puberty, contraception, pregnancy, abortion, and STIs. Having knowledge on the matter lowers the chances of getting infected, which may lead to future dysfunction or even infertility. Moreover, it ensures a higher quality of life, emotional and physical health.
GCT has managed many clinical studies in obstetrics and women’s health, as well as in men’s reproductive health. Please do not hesitate to get in touch with us for more information or to request a feasibility analysis for your study.
Updated: February 12, 2020
Updated: February 4, 2020
We are celebrating the Birthday of Dr. Eugene Selivra, GCT CEO today!
All of us here at Global Clinical Trials feel beyond grateful to work in such a diverse and global, yet family-like environment.
We wish Dr. Selivra a wonderful and successful year ahead and plenty new and exciting projects. Thank you you for setting an example of dedication and passion for work.
Updated: February 4, 2020
As 2020 begins, GCT expands its operations in Asia, adding the Republic of Kazakhstan to its map. Dr. Oleg Kurilov is appointed the GCT General Director in Kazakhstan. He specializes in surgery, urology and nephrology and has a broad expertise working in clinical trials.
Located in Central Asia, Kazakhstan has a population of over 18 million people. It is the world’s largest landlocked country and the ninth largest country in the world. Kazakhstan is part of The Eurasian Economic Union (EAEU). Among many economic and political areas, the union regulates and unifies the pharmaceutical and clinical trials industry. This includes an easier registration of drugs and medical devices, accelerated approval timelines, and a simplified customs and logistics process in other member countries. These advantages make Kazakhstan attractive for both regional and global companies.
In December 2019, the government of Kazakhstan approved the state program for the development and improvement of the country’s Healthcare System for 2020-2050. A significant part of the program is devoted to increasing the number of clinical trials and bringing international clinical trials into the country. Currently, it takes 1 month to receive the approval for a clinical study from the Regulatory Authority. The submission to the Ethics Committee is performed in parallel. This allows study sites to open in just 1.5 months, providing no questions are raised by either authority. It is also worth to mention that all regulatory documentation can be submitted in the Russian language.
“Providing the high quality clinical trial services is always our top priority, and expanding to new regions enhances our operational capabilities. Kazakhstan is a rapidly developing country that is fully compliant with GCP. It is a great option to consider Kazakhstan for a global study to have a diverse patient population and fast enrollment. We are excited to offer this new region to our clients,” – GCT CEO, Dr. Eugene Selivra.
Updated: January 31, 2020
Last week for the 13th time Indian Society for Clinical Research (ISCR) conference took place in Mumbai.The event brings together main influencers of the Indian clinical research society, as well as unites the industry professionals from around the globe. Dr. Eugene Selivra and Nataliya Katsnelson together with the GCT Managing Director, Dr. Umakanta Sahoo participated at this annual conference to discuss new regulations, and how technology meets clinical research assuring the ultimate goal of enhancing patient’s safety.
Updated: January 28, 2020
Due to the team growth and services extension of GCT India, we moved to a new office in Mumbai at end of 2019. While participating at the international conference, CEO, Eugene Selivra, MD and Senior Director of Business Development, Nataliya Katsnelson visited the new facility in one of Mumbai’s business centers.
Updated: January 28, 2020
GCT has successfully concluded enrollment for the Phase III pediatric study of rare neurological disease in Russia. Reaching the exact recruitment number, as predicted and in under 1.5 months marks an important milestone for our company and the Sponsor – US Pharma and GCT long term partner. Together, we were able to meet the projected deliverables despite the demanding timelines, sensitive patient group and limited number of sites that treat this devastating condition in Russia. The treatment phase of the study is now well underway according to the protocol schedule.
Updated: January 22, 2020
Meet GCT team at the ISCR Conference next week in Mumbai! – https://www.iscr.org/iscr-conference-2020/
January, 24-25, GCT CEO, Dr. Eugene Selivra, Country Director, Dr. Umakanta Sahoo and Senior Director of Business Development, Nataliya Katsnelson will be at the summit, which is devoted to bringing together the global and local clinical research community.
To schedule a meeting, please contact us at BD@GCTRIALS.COM.
We look forward to seeing you there!
Updated: January 16, 2020
The thyroid gland is a gland located in the lower front of the neck. It produces thyroid hormones, which are then secreted into the blood and transferred around the body. These hormones are responsible for coordinating many important processes within the body, for example, controlling the body temperature and heart beat. Hence, when the thyroid gland doesn’t function properly, it can result in serious conditions.
The two main types of conditions are Hyperthyroidism and Hypothyroidism. When they occur, the thyroid gland produces too much and too little hormones, accordingly. However the symptoms can be vague – weight loss/gain, depression and fatigue. It is necessary to take a blood test in order to understand how well a thyroid gland works. If a dysfunction is detected, there are a few treatment options available from medications to surgery.
Updated: January 15, 2020
January 11th was the birthday of Karina Osmanova, our Office Manager, and we are having a celebration today at our St. Petersburg office!
All of us at GCT wish for all Karina’s dreams to come true this year.
Happy Birthday, Karina!!
Updated: January 13, 2020
Glaucoma is one of the leading causes of vision loss for people over 60 years old. There are no early symptoms, and nearly half of the people who have glaucoma are unaware of it.
Glaucoma is a group of diseases that affect the optic nerve, a part of the eye that is responsible for transmitting signals from the eye to the brain. When the fluid in the eye doesn’t drain properly, the pressure within the eye increases. It damages the optic nerve and leads to partial or complete vision loss.
As the eye pressure can change throughout the day, a single visit to the ophthalmologist often isn’t enough to detect the disease. This is why it is necessary to have regular eye exams. Depending on the type and severity of glaucoma, several treatment options are available to patients today including eye drop medications and surgery. Even though the loss of vision due to glaucoma is irreversible, treatment helps stop the progression of the disease.
GCT has conducted a number of studies in glaucoma and other eye diseases. Currently we are managing a phase III trial in ocular hypertension or primary open angle glaucoma. We are hopeful about further development of the treatment options’ efficacy.
Updated: January 6, 2020
The New Year has begun, and we have our first GCT employee Birthday to celebrate today!
Csilla Leka is General Director of our office in Hungary, and she has also been a project manager since 2016. We admire Csilla for her hard work, willingness to help out and work ethics.
Wishing Csilla all the best on this special day!
Updated: January 2, 2020
Happy New Year to All our Friends and Partners!!
Updated: December 31, 2019
GCT is awarded a phase IV study to compare the efficacy and safety of two methods of IP administration in patients with acute sore throat. GCT will be managing study in Russia with aim of enrolling up to 160 patients. Apart from clinical monitoring and site management, GCT will be responsible for the full regulatory support and drug importation. The project is currently in the active start-up stage.
Updated: December 24, 2019
It is a special day at GCT Russian office as we are celebrating yet another birthday of our oldest employee. On December 20th we wish Happy Birthday to Anton Romanov, M. Sc. GCT Event Manager.
All the team wishes Anton luck, health and another year of unforgettable memories and adventures!
Updated: December 20, 2019
Among the discussed topics of the 14th Biosimilars Congregation in Mumbai were the regulatory updates, present state of the biosimilars market, product development strategies, challenges, and many more. Dr. Umakanta Sahoo, GCT Managing Director in India was there to examine the latest trends in the biosimilars drug development field together with the industry experts. The meeting was truly insightful and turned into a major international networking platform.
Updated: December 17, 2019
GCT President, Dr. Jeffrey Apter has recently attended two major conferences on brain health and Alzheimer’s. CTAD (Clinical Trials on Alzheimer’s Disease) took place in San Diego, 4-7 December. The attendees discussed the development of the next generation of the Alzheimer’s Disease treatments. It was followed by the ACNP (The American College of Neuropshychopharmacology) 58th annual meeting in Orlando, FL on 8-11 December, and focused on brain behavior-drug interactions and most recent advances in psychopharmacology.
Both meetings were highly successful and informative, and offered a great networking opportunity.
Updated: December 12, 2019
If you are joining us at the 14th Biosimilars Congregation 2019 in Mumbai, please do not hesitate to email firstname.lastname@example.org to schedule a meeting. Dr. Umakanta Sahoo, GCT-India Managing Director, will be there at the conference and will be glad to discuss the aspects of planning a successful clinical trial India, Eastern Europe, Russia and the US. The conference takes place on the 12th of December at Kohinoor Continental Hotel, and its focus is on the development, manufacturing and commercialization of biosimilars.
Updated: December 9, 2019